Funded Tech Companies

Eliem Therapeutics

Wondering who backed Eliem Therapeutics? Access Industries, Intermediate Capital Group and Acorn Bioventures joined the equity holders in this innovative biopharmaceutical company.

Company Overview

Contact Information

Company Background Information

Overview

At its core, Eliem is motivated by the promise of helping people live happier, more fulfilling lives. The Eliem team channels its experience, energy and passion for improving patients' quality of life by developing life-changing novel therapies for neuronal excitability disorders based on clinically validated mechanisms of action.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

8/10/2021

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Robert Azelby

        

Chief Medical Officer

Amy Chappell

        

Chief Operating Officer

Erin Lavelle

        

VP - Bus. Development

Jo Palmer-Phillips

        

VP - General Counsel

James Bucher

        

VP - R & D

Valerie Morisset

        

Company Investors

• Access Industries
• Intermediate Capital Group
• Acorn Bioventures
• Samlyn Capital
• RA Capital (Andrew Levin)
• LifeArc

Browse more funded tech companies:

Elicit Plant | Eligible

Share this article

About Our VC Funding Database

This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary